CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 340,565	$ 228,713
Marketable securities, at fair value	202,144	67,546
Accounts receivable, net	104,964	106,843
Inventories	21,834	29,526
Prepaid assets	14,618	11,547
Assets held for sale	10,050	0
Other current assets	15,755	4,555
Total current assets	709,930	448,730
Property and equipment (net of accumulated depreciation of $112,185 and $92,895, respectively)	107,172	85,873
Operating lease right-of-use assets	102,310	45,786
Intangible assets, net	450,802	120,653
Goodwill	525,802	211,083
Restricted cash	3,161	21,919
Investment in non-consolidated affiliate	0	29,555
Prepaid lease asset	0	20,229
Other assets	7,210	4,503
Total non-current assets	1,196,457	539,601
Total assets	1,906,387	988,331
Current liabilities
Accounts payable	28,536	24,965
Accrued compensation	32,283	24,727
Accrued expenses and other liabilities	18,088	11,654
Current portion of equipment financing obligations	1,564	2,841
Current portion of operating lease liabilities	6,988	4,967
Pharma contract liabilities	5,278	4,029
Total current liabilities	92,737	73,183
Long-term liabilities
Convertible senior notes, net	531,779	168,120
Equipment financing obligations	152	967
Operating lease liabilities	72,336	42,296
Deferred income tax liabilities, net	57,706	5,415
Other long-term liabilities	14,432	4,056
Total long-term liabilities	676,405	220,854
Total liabilities	769,142	294,037
Commitments and contingencies (Note 14)
Stockholders’ equity
Common stock, $0.001 par value, (250,000,000 shares authorized; 123,217,010 and 112,075,474 shares issued and outstanding, respectively)	123	112
Additional paid-in capital	1,110,590	701,357
Accumulated other comprehensive (loss) income	(390)	10
Retained earnings (accumulated deficit)	26,922	(7,185)
Total stockholders’ equity	1,137,245	694,294
Total liabilities and stockholders’ equity	$ 1,906,387	$ 988,331